Featured Story | By Nick Paul Taylor AstraZeneca has taken another step toward bringing its COVID-19 antibody cocktail to market, filing for emergency use authorization of the long-acting candidate in coronavirus prophylaxis in the U.S. read more |
| |
|---|
|
Top Stories By Ben Adams The search is on for a new director of the National Institutes of Health as long-serving Francis Collins, M.D., Ph.D., announced his decision to retire by the end of 2021. read more By Nick Paul Taylor Gemini Therapeutics is betting it all on its clinical-phase eye disease prospect. Having built up early-stage activities in gene therapy and other areas, Gemini is now sweeping those programs aside to focus on the lead program. read more Sponsored By: Taconic Biosciences Pressure to get results in drug discovery and development is unprecedented and the need for genetically engineered custom mouse models is greater than ever. Innovative thinking is getting these critical models into researchers hands faster. read more By Kyle LaHucik BioMarin Pharmaceutical hired Harold Bernstein as chief medical officer and senior vice president after leading translational medicine work at Vertex. The California biotech also snagged Ganesh Vedantham from Amgen to fill the role of senior vice president of technical development. read more Sponsored by: Almac Group PanCan utilised Almac's IRT expertise to accelerate their adaptive platform outcomes and improve patient care. Find out how here. read more By Kyle LaHucik Just five months after debuting with a nanobody licensed from Merck KGaA, MoonLake Immunotherapeutics is headed to Wall Street. The Swiss biotech is linking arms with blank-check company Helix Acquisition in a SPAC deal that will give MoonLake $230 million in proceeds. read more By Kyle LaHucik Already backed by Novartis, Exo Therapeutics has added $78 million to the bank to fund preclinical development of four potential drug candidates that target exosites. The goal is for the small molecules to be more selective and less toxic in potentially treating various cancers and inflammatory diseases. read more By Kyle LaHucik IpiNovyx Bio is launching with $10 million in seed funding from Eli Lilly, Viva Biotech's incubator and other venture capital firms, aiming to take its first candidate into the clinic in 2023. The company is going after inflammatory and autoimmune diseases. read more By Andrea Park The brain stimulation system includes a small device implanted on the patient’s brain that continuously monitors neurological activity and instructs two leads in separate areas of the brain to emit pulses if abnormal activity is detected. read more By Robert King Employer health plans cannot deny benefits to customers who don't get vaccinated for COVID-19 but they can offer premium discounts for getting vaccinated, new CMS guidance says. read more By Eric Sagonowsky AstraZeneca has already faced one high-profile personnel issue this year in a case that resulted in a $2.4 million jury award for a former sales manager. Now, the company is paying up to resolve allegations of race- and gender-based pay discrimination for hundreds of sales reps. read more Resources Sponsored By: Trial Interactive Check out the eTMF Implementation Quick Guide to see a checklist TMF experts developed to help you reduce risks, maintain compliance, and establish effective processes in your eTMF. Sponsored By: Bioclinica This whitepaper addresses where AI can make the biggest impact in clinical trials. Sponsored by: Thermo Fisher Scientific Looking to accelerate your biotech company, but not sure where to start? Sponsored by: Drexel University Online Drexel University’s online graduate programs in biomedicine, clinical research, drug discovery, and molecular medicine were developed with working professionals in mind, providing you with the education, practical skills, and competitive edge you need to be successful in your career. Learn more. Sponsored by: Oracle Health Sciences New research indicates an accelerated adoption of decentralized clinical trials due to COVID-19. Sponsored by: LabVantage Solutions Shift from data collection to data science. Add advanced analytics to your lab informatics platform to yield valuable, action-ready insights from LIMS and other data. Sponsored by: Thermo Fisher Scientific Integrate supply chain simulation into your early clinical trial planning to minimize risk in an uncertain supply chain environment, improve supply chain outcomes, and help streamline time-to-market for innovative therapies. Sponsored by: WCG Every biopharma sponsor faces the challenge of initiating, running and closing trials on time, but oncology studies pose several unique hurdles. Sponsored by: Box Read Get to Know Cloud Content Management for Life Sciences and learn how to eliminate silos across all workflows, from R&D to commercialization. Sponsored by: Catalent Learn about drug product process development challenges and risks, the difference between innovator and biosimilar drug product process development, and more during the drug product process development phase. Sponsored by: Catalent Get insights on key considerations for a successful tech transfer process for manufacturing a biologic drug product, including a case study on overcoming challenges in a process transfer for a sterile diluent. | 
